Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03868553 Completed - Clinical trials for Header Frequencies, Head Injuries

Header Burden in Football (Soccer)

Start date: January 1, 2018
Phase:
Study type: Observational

To assess the realistic magnitude of the header burden in children's and youth' football in eight European countries. In a cross-sectional observational design, one match of 60 different teams in each of the eight European countries were monitored via video recording throughout the second half of the regular season 2017/18 and the first half of the regular season 2018/19. Clubs with (female, male, or mixed) Under-10, Under-12 and female and male Under-16 teams were invited to participate. Header frequencies and types were analysed using standardized heading registration forms. Additionally, head injuries were recorded using standardized head injury registration forms.

NCT ID: NCT03868514 Completed - Breast Cancer Clinical Trials

Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket)

PRO-Pocket
Start date: July 4, 2019
Phase:
Study type: Observational

"PRO-Pocket" - International prospective multicentre Post Market Clinical Follow Up to "Patient reported outcome" in primary or secondary breast reconstruction after mastectomy using a titanised polypropylene mesh (TiLOOP® Bra Pocket)

NCT ID: NCT03868358 Completed - Schizophrenia Clinical Trials

Effect of Intermittent Theta Burst Stimulation (iTBS) for Alleviating Symptoms of Schizophrenia Patients

Start date: May 21, 2017
Phase: N/A
Study type: Interventional

To investigate the treatment effect of intermittent theta-burst transcranial magnetic stimulation on symptomatic relief of schizophrenia patients, and the underlying neural mechanism by functional MRI and the resting electroencephalogram

NCT ID: NCT03868020 Completed - Clinical trials for Metastatic Head and Neck Squamous Cell Carcinoma

Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

Start date: April 24, 2019
Phase: Early Phase 1
Study type: Interventional

This early phase I trial studies how well fluciclovine F18 positron emission tomography (PET)/computed tomography (CT) works in identifying the origin of head and neck squamous cell carcinoma in patients with cancer that has spread to the cervical lymph nodes. Fluciclovine F18 during a PET/CT scan may work better in helping doctors learn where the cancer started (called the site of origin) and directing treatment planning compared to standard fludeoxyglucose F-18 (FDG) PET-CT scans.

NCT ID: NCT03867916 Completed - Malignant Neoplasm Clinical Trials

Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients

Start date: December 13, 2018
Phase: N/A
Study type: Interventional

This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve the care provided to Asian American cancer patients.This study is offered in the following languages in addition to English: Chinese (Cantonese or Mandarin) and Vietnamese.

NCT ID: NCT03867838 Completed - Clinical trials for Arm Weakness as a Consequence of Stroke

Effects of a Compliant Arm Support on Post-stroke Upper Extremity Range of Motion

Start date: June 14, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to show that a wearable compliant arm support consisting of inflatable bladders with adjustable straps to connect them to the waist and arm can meaningfully increase the reachable workspace of persons with post-stroke arm weakness.

NCT ID: NCT03867461 Completed - Clinical trials for Idiopathic Intracranial Hypertension

The Effects of MAP and EtCO2 on Venous Sinus Pressures

Start date: June 20, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to further elaborate the role of both arterial blood pressure and end-tidal carbon dioxide concentration on measured venous pressures.

NCT ID: NCT03867253 Completed - Clinical trials for Mild to Moderate Alzheimer's Disease

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease

ETHERAL-US
Start date: May 16, 2019
Phase: Phase 2
Study type: Interventional

This is a Phase IIa study assessing the safety, tolerability and preliminary efficacy of ORY-2001 in mild to moderate Alzheimer's Disease patients.

NCT ID: NCT03867097 Completed - Clinical trials for Raynaud Phenomenon Secondary to Systemic Sclerosis

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Start date: March 4, 2019
Phase: Phase 2
Study type: Interventional

This is a Phase 2, multicenter, double-blind, randomized, placebo-controlled study to evaluate the effect of iloprost on the symptomatic relief of Raynaud's Phenomenon attacks in subjects with symptomatic Raynaud's Phenomenon secondary to Systemic Sclerosis.

NCT ID: NCT03867019 Completed - Vertigo Clinical Trials

The Cardiac Autonomic Control System Response to Vestibular Stimulation in Subjects With and Without BPPV

Start date: April 28, 2019
Phase:
Study type: Observational

The vestibular system in the inner year is an important system in the body which is responsible for balance. In addition, there is evidence that the vestibular system plays a role in maintaining blood pressure while changing body position, such as moving from lying down in bed to sitting. Dysfunction of the vestibular system may affect the ability to maintain blood pressure, therefore the aim of this study is to assess if a specific problem in the vestibular system (Benign Paroxysmal Positional Vertigo- BPPV) may cause changes in the interaction between the vestibular system and the cardiovascular system. We assume that patients with this medical condition (BPPV) will have different heart rate parameters in comparison with healthy patients.